☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
trastuzumab emtansine
Chugai's Kadcyla (trastuzumab emtansine) Receives MHLW's Approval for Adjuvant Therapy of HER2-Positive Early Breast Cancer
August 24, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.